Early notification – Bosvate
New listing in both the Pharmaceutical Schedule Section B and Section H (HML) from 1 July 2017.
Bosvate Tab 2.5mg, 5 mg and 10 mg 90 tablet blister packs.
Reference pricing for 30 tablet blister packs will apply from 1 September 2017 with delisting from HML 1 September 2017 and Pharmaceutical Schedule 1 December 2017.
Further information is provided on our website under Pharmac Changes.
As of the date of this notification ProPharma / PWR cannot accept Bosvate 30 pack for credit under any circumstances.